Pharmacoepidemiology and Drug Safety 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.---
Pharmacoepidemiology and Drug Safety, Ahead of Print. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 2, 2018 Category: Drugs & Pharmacology Source Type: research
Issue Information
No abstract is available for this article. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 2, 2018 Category: Drugs & Pharmacology Tags: ISSUE INFORMATION Source Type: research
Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data
ConclusionsData from electronic health records can be used to accurately identify adults with type 1 diabetes. When identifying adults with type 1 diabetes, we recommend either a modified version of the Klompas algorithm without the urine acetone test strips criterion or the requirement that the majority of diabetes diagnosis codes be type 1 codes. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 2, 2018 Category: Drugs & Pharmacology Authors: Emily B. Schroeder, William T. Donahoo, Glenn K. Goodrich, Marsha A. Raebel Tags: ORIGINAL REPORT Source Type: research
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools
ConclusionsThis analysis demonstrated the ability to use Sentinel tools to assess the effectiveness of a label change and accompanying communication at the population level and suggests an influence on subsequent dispensing behavior. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Rachel E. Sobel, Andrew Bate, James Marshall, Kevin Haynes, Nandini Selvam, Vinit Nair, Gregory Daniel, Jeffrey S. Brown, Robert F. Reynolds Tags: ORIGINAL REPORT Source Type: research
Addressing unmeasured confounding in comparative observational research
ConclusionWhen assessing comparative effectiveness or safety in observational research, the impact of unmeasured confounding should not be ignored. Instead, we suggest quantitatively evaluating the impact of unmeasured confounding and provided a best practice recommendation for selecting appropriate analytical methods. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Xiang Zhang, Douglas E. Faries, Hu Li, James D. Stamey, Guido W. Imbens Tags: ORIGINAL REPORT Source Type: research
New statin use and left ventricular structure: Estimating long ‐term associations in the Multi‐Ethnic Study of Atherosclerosis (MESA)
ConclusionsIn contrast to previous small studies, we found very modest associations between statin use and indices of left ventricular remodeling over 10 years in this prospective study of a diverse cohort. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Lauren N. Strand, Rebekah L. Young, Alain G. Bertoni, David A. Bluemke, Gregory L. Burke, Joao A. Lima, Nona Sotoodehnia, Bruce M. Psaty, Robyn L. McClelland, Susan R. Heckbert, Joseph A. Delaney Tags: ORIGINAL REPORT Source Type: research
Exceeding the daily dosing limit of nonsteroidal anti ‐inflammatory drugs among ibuprofen users
ConclusionsThe prevalence of EDL among NSAID users is nontrivial, and it is associated with potentially modifiable factors. Educating consumers about NSAIDs and their dosing directions could reduce excess dosing. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: David W. Kaufman, Judith P. Kelly, Deena R. Battista, Mary Kathryn Malone, Rachel B. Weinstein, Saul Shiffman Tags: ORIGINAL REPORT Source Type: research
Risk of rhabdomyolysis from 5 ‐α reductase inhibitors
Conclusion5‐α reductase inhibitors do not appear to be associated with the development of rhabdomyolysis; however, they may be associated with an increased risk of myopathy and myositis. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Blayne Welk, Eric McArthur, Michael Ordon, Jade Dirk, Stephanie Dixon, Amit X. Garg Tags: BRIEF REPORT Source Type: research
Trends and uptake of new formulations of controlled ‐release oxycodone in Canada
ConclusionsThe changing availability of tamper‐deterrent and non‐tamper‐deterrent formulations of controlled‐release oxycodone in Canada has had variable influence on the rate of use of these products across Canada. Future research should explore whether the availability of generic controlled‐release oxycodone has led to measurable changes in the safety of oxycodone use in Canada. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Tara Gomes, Sonia Jain, J. Michael Paterson, Ingrid Sketris, Patricia Caetano, David Henry, Tags: ORIGINAL REPORT Source Type: research
Drug adherence in treatment resistant and in controlled hypertension —Results from the Swedish Primary Care Cardiovascular Database (SPCCD)
ConclusionsPatients with multiple antihypertensive drug therapy had similar decline in adherence over time regardless of initial blood pressure control. Diabetes was associated with better adherence, which may imply that the structured caregiving of these patients enhances antihypertensive drug treatment. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Lina Holmqvist, Kristina Bengtsson Bostr öm, Thomas Kahan, Linus Schiöler, Miriam Qvarnström, Björn Wettermark, Per Hjerpe, Jan Hasselström, Karin Manhem Tags: ORIGINAL REPORT Source Type: research
Beta testing the potential link between the alpha antagonist tamsulosin and dementia
(Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Sudeep S. Gill, Anthony D. Bai Tags: COMMENTARY Source Type: research
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)
(Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Xavier Kurz, Susana Perez ‐Gutthann, Tags: COMMENTARY Source Type: research
Relevance of frailty to mortality associated with the use of antipsychotics among community ‐residing older adults with impaired cognition
ConclusionsRisk of antipsychotic‐associated mortality was highest in the first month following exposure, varied significantly by client frailty, and was greater among men than among women. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Colleen J. Maxwell, Michael A. Campitelli, David B. Hogan, Christina Diong, Peter C. Austin, Joseph E. Amuah, Kate Lapane, Dallas P. Seitz, Sudeep S. Gill, Andrea Gruneir, Walter P. Wodchis, Susan E. Bronskill Tags: ORIGINAL REPORT Source Type: research
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System
ConclusionsThis study demonstrates the capability of Sentinel to conduct prospective safety monitoring and raises no new concerns about rivaroxaban safety. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - January 1, 2018 Category: Drugs & Pharmacology Authors: Elizabeth A. Chrischilles, Joshua J. Gagne, Bruce Fireman, Jennifer Nelson, Sengwee Toh, Azadeh Shoaibi, Marsha E. Reichman, Shirley Wang, Michael Nguyen, Rongmei Zhang, Rima Izem, Margie R. Goulding, Mary Ross Southworth, David J. Graham, Candace Fuller, Tags: ORIGINAL REPORT Source Type: research
